BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 10459896)

  • 1. Is intensive drug therapy appropriate for older patients?
    Gollub SB
    Lancet; 1999 Mar; 353(9157):940-1. PubMed ID: 10459896
    [No Abstract]   [Full Text] [Related]  

  • 2. Aspirin, heparin, and fibrinolytic therapy in suspected acute myocardial infarction.
    Collins R; Peto R; Baigent C; Sleight P
    N Engl J Med; 1997 Mar; 336(12):847-60. PubMed ID: 9062095
    [No Abstract]   [Full Text] [Related]  

  • 3. Challenging the conclusions drawn in "Thrombolysis for acute myocardial infarction: drug review".
    Howlett M
    MedGenMed; 2002 Feb; 4(1):6; author reply 7. PubMed ID: 11965208
    [No Abstract]   [Full Text] [Related]  

  • 4. Reduced tissue factor pathway inhibitor-1 after pharmacological thrombolysis: an epiphenomenon or potential culprit in rethrombosis?
    Shah PK
    Circulation; 2002 Jan; 105(3):270-1. PubMed ID: 11804975
    [No Abstract]   [Full Text] [Related]  

  • 5. Adherence to national guidelines for drug treatment of suspected acute myocardial infarction: evidence for undertreatment in women and the elderly.
    McLaughlin TJ; Soumerai SB; Willison DJ; Gurwitz JH; Borbas C; Guadagnoli E; McLaughlin B; Morris N; Cheng SC; Hauptman PJ; Antman E; Casey L; Asinger R; Gobel F
    Arch Intern Med; 1996 Apr; 156(7):799-805. PubMed ID: 8615714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Follow up antithrombotic therapy after thrombolysis].
    Nakamura Y
    Nihon Rinsho; 1994 Jul; 52 Suppl(Pt 1):825-31. PubMed ID: 12436623
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin augmentation of the efficacy of thrombolysis.
    O'Donnell CJ; Jonas MA; Hennekens CH
    Coron Artery Dis; 1995 Dec; 6(12):936-9. PubMed ID: 8723015
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-effectiveness of intravenous thrombolytic drugs for acute myocardial infarction.
    Naylor CD; Bronskill S; Goel V
    Can J Cardiol; 1993; 9(6):553-8. PubMed ID: 8221354
    [No Abstract]   [Full Text] [Related]  

  • 9. Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation.
    Sabatine MS; Cannon CP; Gibson CM; López-Sendón JL; Montalescot G; Theroux P; Claeys MJ; Cools F; Hill KA; Skene AM; McCabe CH; Braunwald E;
    N Engl J Med; 2005 Mar; 352(12):1179-89. PubMed ID: 15758000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin after thrombolysis for MI.
    Seaton TL
    J Fam Pract; 1997 Mar; 44(3):249-50. PubMed ID: 9071241
    [No Abstract]   [Full Text] [Related]  

  • 11. [Relationship between mortality due to acute myocardial infarction and adherence to clinical guidelines].
    Coma-Canella I
    Rev Esp Cardiol; 2006 Mar; 59(3):189-92. PubMed ID: 16712740
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of drug treatment of myocardial infarction in public hospitals of Andalusia. GAUME (Andalusian Group for performance of Studies on Drug Utilization)].
    Bautista Paloma FJ; Muñoz Muñoz N; Gordillo Rueda E; Santos Ramos B; Cobos García FJ; Guerrero Aznar MD
    Med Clin (Barc); 1998 Sep; 111(9):329-35. PubMed ID: 9810534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials.
    Yusuf S; Sleight P; Held P; McMahon S
    Circulation; 1990 Sep; 82(3 Suppl):II117-34. PubMed ID: 1975522
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multi-drug management after myocardial infarct].
    Kritz H; Sinzinger H
    Wien Klin Wochenschr; 1997; 109 Suppl 2():17-24. PubMed ID: 9340918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-blockers and antithrombotics for secondary prevention after myocardial infarction.
    Ball SG
    Eur Heart J; 1998 Jan; 19(1):14-5. PubMed ID: 9503172
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pulmonary hemorrhage after thrombolysis in acute myocardial infarct].
    Rodríguez Blanco VM; Barriales Alvarez V; Morís de la Tassa C
    An Med Interna; 1997 Apr; 14(4):209. PubMed ID: 9181820
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of diabetes mellitus on survival after myocardial infarction: can it be modified by drug treatment? Results of a population-based myocardial infarction register follow-up study.
    Löwel H; Koenig W; Engel S; Hörmann A; Keil U
    Diabetologia; 2000 Feb; 43(2):218-26. PubMed ID: 10753044
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival after myocardial infarction in the nineties. Results of a prospective registry and their implications as to identification of an increased risk of death and especially sudden death].
    Jordaens L; Tavernier R
    J Med Liban; 1999; 47(3):181-9. PubMed ID: 10550944
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical impact of local implementation of agreed guidelines for the management of patients with acute myocardial infarction.
    Badano L; Cassin M; Solinas L; Burelli C; Macor F; Zanuttini D
    G Ital Cardiol; 1999 Jan; 29(1):39-47. PubMed ID: 9987046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment of myocardial infarct with anticoagulants, thrombolytics, inhibitors of platelet aggregation and beta receptor blockaders].
    Thiele R
    Z Arztl Fortbild (Jena); 1984; 78(5):167-71. PubMed ID: 6202068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.